Home › Non-Hodgkin Lymphoma › New York › The Bronx
Non-Hodgkin Lymphoma clinical trials in The Bronx, NY
5 studies for Non-Hodgkin Lymphoma are looking for participants at sites in and around The Bronx (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Montefiore Medical Center, The Bronx
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Montefiore Medical Center - Moses Campus, The Bronx
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Children's Hospital at Montefiore, The Bronx
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Montefiore Medical Center-Einstein Campus, The Bronx
- Montefiore Medical Center - Moses Campus, The Bronx
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- Montefiore Medical Center, The Bronx
Non-Hodgkin Lymphoma trials in other cities
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Washington, DC18 studies
- Atlanta, GA18 studies
- Chicago, IL18 studies
- Milwaukee, WI18 studies
- Columbus, OH18 studies
- Dallas, TX17 studies
Other studies in The Bronx
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer17 studies
- Acute Myeloid Leukemia15 studies
- Lung Cancer13 studies
- Cancer (all types)12 studies
- Cardiovascular Disease12 studies
- Heart Failure11 studies
- Prostate Cancer11 studies
- Metastatic Cancer9 studies
- Colorectal Cancer9 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Myelodysplastic Syndromes9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.